Visual field compression by a non-secreting pituitary tumour during pregnancy

Journal of the Royal Society of Medicine

Volumn 96, Issue 1, 2003, Pages 27-28

  Masding, Mike G ^a,b   Lees, P D ^a   Gawne Cain, M L ^a   Sandeman, D D ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CLOMIFENE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; MEDROXYPROGESTERONE ACETATE; PROLACTIN;

ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; IMAGE ANALYSIS; INFERTILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOMENORRHEA; OPTIC CHIASM; PREGNANCY; PROLACTIN BLOOD LEVEL; TREATMENT OUTCOME; VISUAL DISORDER; VISUAL FIELD DEFECT;

EID: 0037243416     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.96.1.27     Document Type: Article

References (6)

1. Gonzalez JG, Elizondo G, Salvidar D, Nanez H, Todd LE, Villarreal JZ. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988;85:217-20
2. Magyar DM, Marshall JR. Pituitary tumors and pregnancy. Am J Obstet Gynecol 1978;132:739-51
3. Bevan JS, Webster J, Burke Scanlon MF. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992;13:220-40
4. Wollensen F, Andersen T, Karle A. Size reduction of extra-sellar pituitary tumour during bromocriptine. Quantitation of effects on different types of tumours. Ann Intern Med 1982;96:281-6
5. D'Emden MC, Harrison LC. Rapid improvement in visual field defects following bromocriptine treatment of patients with non-functioning pituitary adenomas. Clin Endocrinol 1986;25:697-702
6. Grossman A, Wass JAH, Besser GM. [Letter]. Clin Endocrinol 1987;26:651